Growth Metrics

Itron (ITRI) Cash & Equivalents (2016 - 2026)

Itron filings provide 18 years of Cash & Equivalents readings, the most recent being $712.8 million for Q1 2026.

  • On a quarterly basis, Cash & Equivalents fell 36.54% to $712.8 million in Q1 2026 year-over-year; TTM through Mar 2026 was $712.8 million, a 36.54% decrease, with the full-year FY2025 number at $1.0 billion, down 2.93% from a year prior.
  • Cash & Equivalents hit $712.8 million in Q1 2026 for Itron, down from $1.0 billion in the prior quarter.
  • In the past five years, Cash & Equivalents ranged from a high of $1.3 billion in Q3 2025 to a low of $196.0 million in Q1 2023.
  • Median Cash & Equivalents over the past 5 years was $302.0 million (2023), compared with a mean of $616.7 million.
  • Biggest five-year swings in Cash & Equivalents: plummeted 64.5% in 2022 and later soared 295.49% in 2024.
  • Itron's Cash & Equivalents stood at $202.0 million in 2022, then soared by 49.52% to $302.0 million in 2023, then surged by 248.04% to $1.1 billion in 2024, then dropped by 2.93% to $1.0 billion in 2025, then crashed by 30.14% to $712.8 million in 2026.
  • The last three reported values for Cash & Equivalents were $712.8 million (Q1 2026), $1.0 billion (Q4 2025), and $1.3 billion (Q3 2025) per Business Quant data.